Treatment of recurrent stroke and pulmonary thromboembolism with percutaneous closure of a patent foramen ovale and placement of inferior vena cava filter

Catheterization and Cardiovascular Interventions

Volumn 58, Issue 3, 2003, Pages 413-415

  Donti, Andrea ^a,b   Giardini, Alessandro ^a   Formigari, Roberto ^a   Bronzetti, Gabriele ^a   Prandstraller, Daniela ^a   Bonvicini, Marco ^a   Picchio, Fernando M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anticoagulation; Cardiac catheterization; Interatrial septum; Transesophageal echo

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM SEPTUM DEFECT; HUMAN; INFERIOR CAVA VEIN; LUNG EMBOLISM; RECURRENT DISEASE; RISK FACTOR; STROKE; TREATMENT OUTCOME; VENA CAVA FILTER;

ADULT; BALLOON OCCLUSION; CEREBROVASCULAR ACCIDENT; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; PULMONARY EMBOLISM; RECURRENCE; VENA CAVA FILTERS;

EID: 0037372897     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10446     Document Type: Article

References (11)

1. Overall JR, Bone I, Lees KR. Interatrial septal anormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
2. Meacham RR, Headley AS, Bronze MS, Lewis JB, Rester MM. Impending paradoxical embolism. Arch Intern Med 1998;158:438-448.
3. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-522.
4. Kasper W, Geibel A, Tiede N, Just H. Patent foramen ovale in patients with haemodinamically signoficant pulmonary embolism. Lancet 1992;340:561-564.
5. Kostantidines S, Geibel A, Kasper W, Olschewski M, Blumel L, Just H. Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 1998;97:1946-1951.
6. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G, Lausanne Stroke With Paradoxical Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne study. Neurology 1996;46:1301-1305.
7. Mas JL, Zuber M. French study group on patent foramen ovale and atrial septal aneurism: recurrent cerebrovascular events in atients with patent foramen ovale, atrial septal aneurism, or both and cryptonenic stroke or transient ischemic attack. Am Heart J 1995;130:1083-1088.
8. Lechat P, Mas JL, Lascault G, et al. Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. J Neurol Sci 1998;160:158-160.
9. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurism or both. N Engl J Med 2001;345:1740-1746.
10. Nendaz MR, Sarasin FP, Junod AF, Bogousslavsky J. Preventing stroke recurrence in patients with patent foramen ovale: anti-thrombotic therapy, foramen closure, or therapeutic abstension? - a decision analytic perspective. Am Heart J 1998;135:532-541.
11. Nedeltchev K, Arnold M, Wahl A, Sturzenegger M, Vella EE, Windecker S, Meier B, Mattle HP. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurosurg Psychiatry 2002;72:347-350.